Inquis Medical Valuation, Funding & Investors

Bioheng is a Chinese biopharma company developing cell and gene therapies for cancer and autoimmune diseases. Founded in 2017 and based in Shanghai, the firm operates a GMP facility producing CAR-T cells and engineered NK cells. Bioheng received investment from Simcere Pharmaceutical Group and advances clinical trials for solid tumors in China.

Pi-Cardia is an Israeli medical technology company based in Rehovot that develops non-implant, catheter-based devices for treating heart valve calcification, particularly aortic stenosis, without requiring valve replacement. Its ShortCut leaflet modification device, cleared by the FDA, is used to modify diseased valve leaflets ahead of complex transcatheter aortic valve replacement (TAVR) procedures, including cases at risk of coronary obstruction during valve-in-valve TAVR. The company's earlier Leaflex technology used mechanical scoring to fracture calcified valve leaflets and restore valve mobility as a potential alternative to TAVR for heavily calcified or bicuspid valves.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

JETEMA Co Ltd is a bio venture company. It offers products such as Botulinum toxin, Filler, Anti-aging solutions. The company also offers medical devices and cosmetics.

Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company’s technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.